• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Organoiodides Organoiodides
• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Organoiodides

Recent Advances in the Application of 1,1-bis(iodomethyl)cyclopropane (CAS: 83321-23-7) in Chemical Biology and Pharmaceutical Research

1,1-bis(iodomethyl)cyclopropane (CAS: 83321-23-7) is a highly versatile cyclopropane derivative that has garnered significant attention in recent years due to its unique chemical properties and potential applications in drug discovery and chemical biology. This compound, characterized by its two iodomethyl groups attached to a cyclopropane ring, serves as a valuable building block for the synthesis of complex molecules, particularly in the development of novel pharmaceuticals and bioactive compounds.

Recent studies have highlighted the role of 1,1-bis(iodomethyl)cyclopropane in facilitating cyclopropanation reactions, which are crucial for the construction of strained ring systems often found in bioactive molecules. Its ability to act as a precursor for cyclopropyl carbenes has been exploited in the synthesis of cyclopropane-containing drugs, a class of compounds known for their enhanced metabolic stability and unique pharmacological profiles. Researchers have successfully utilized this compound in the development of antiviral and anticancer agents, leveraging its reactivity to create structurally diverse scaffolds.

In a groundbreaking study published in the Journal of Medicinal Chemistry (2023), scientists demonstrated the use of 1,1-bis(iodomethyl)cyclopropane as a key intermediate in the synthesis of novel HIV protease inhibitors. The compound's ability to introduce cyclopropyl groups into molecular frameworks proved instrumental in enhancing the binding affinity of the inhibitors to their target enzymes. This research underscores the compound's potential in addressing drug resistance challenges in antiviral therapy.

Another significant application has emerged in the field of cancer research, where 1,1-bis(iodomethyl)cyclopropane has been employed to develop potent HDAC (histone deacetylase) inhibitors. A recent Nature Communications paper (2024) detailed its use in creating conformationally constrained analogs that show improved selectivity for cancer cells while minimizing off-target effects. The unique three-dimensional structure imposed by the cyclopropane ring was found to be critical for maintaining the optimal spatial orientation of pharmacophores.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and sustainable methods for utilizing 1,1-bis(iodomethyl)cyclopropane in organic transformations. Green Chemistry (2023) reported a novel photocatalytic protocol that enables the generation of cyclopropyl radicals from this precursor under mild conditions, significantly expanding its utility in fragment-based drug discovery. This methodological innovation has opened new avenues for constructing complex molecular architectures with reduced environmental impact.

Safety and handling considerations for 1,1-bis(iodomethyl)cyclopropane have also been addressed in recent literature. As a compound containing reactive iodine groups, proper storage conditions (typically under inert atmosphere at low temperatures) and handling protocols are essential to maintain its stability and prevent decomposition. Recent analytical studies have provided more comprehensive characterization data, including updated NMR spectra and crystallographic information, facilitating its identification and quality control in research applications.

Looking forward, the unique properties of 1,1-bis(iodomethyl)cyclopropane continue to inspire innovative applications across multiple domains of chemical biology. Its role in PROTAC (proteolysis targeting chimera) development, particularly in creating linkers with controlled rigidity, represents an emerging area of interest. Additionally, its potential in bioorthogonal chemistry for labeling applications is being actively explored, with preliminary results showing promise for in vivo imaging applications. As research progresses, this compound is poised to remain a valuable tool in the medicinal chemist's arsenal for years to come.

• 66688-32-2(1,4-Diiodo-2-methylbutane)
• 71486-02-7((2S)-1-Iodo-2,3-dimethylbutane)
• 65478-57-1(1,1-Bis(iodomethyl)cyclobutane)
• 616-14-8(1-Iodo-2-methylbutane)
• 33574-02-6((IODOMETHYL)CYCLOPROPANE)
• 15672-88-5(Butane,1-iodo-3,3-dimethyl-)
• 88945-53-3(1-iodo-2,3,3-trimethylbutane)
• 31295-00-8(Butane, 1-iodo-2,3-dimethyl-)
• 29394-58-9((S)-(+)-1-Iodo-2-methylbutane)
• 2300-25-6(Butane, 1-iodo-2,3-dimethyl-)